Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Infectious Disease Trials
Contact Name Clinical Trials at Rush
Contact Phone (312) 942-5498
Contact E-mail clinical_trials@rush.edu

Click on links below to learn about clinical research trials in infectious diseases. If no studies are listed, call (312) 942-5498 to inquire about research under way. If you would like to make an appointment with a physician at Rush, call (888) 352-RUSH, our toll-free referral line.

Included in this section:

Chronic HBV Infection Study: A study of Entecavir in Blacks/African Americans and Hispanics with chronic HBV infection.

HIV AIDS Clinical Trial: A Phase IIIB, Randomized, Trial of Open-label Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) with another PI in Combination with Double-Blind Comparison of two Nucleoside Reverse Transcriptase Inhibitor (NRTI) or a different NRTI in Antiretroviral-NaWve Subjects

HIV Infection (Initial Therapy): A phase III, randomized, open-label study of initial therapy for HIV-1 infection

HIV positive women: The purpose of this trial is to assess the immunogenicity, safety and tolerability of the quadrivalent human papillomavirus (HPV) recombinant vaccine (GARDASIL)directed against virus types 6, 11, 16, and 18.

HIV+ With Resistance to NRTIs and NNRTIs: A randomized strategy study for HIV-1-infected treatment-experienced subjects using the cPSS to select an effective regimen.

HIV/AIDS Clinical Trial: The study is being done at Rush University Medical Center in Chicago, Illinois, to learn if treating people during early HIV infection is beneficial. This study will evaluate how safe and effective a combination of anti-HIV drugs is for people with recently acquired HIV infection.

HIV/AIDS Promoting Maternal and Infant Survival Everywhere: The study at Rush University Medical Center in Chicago, Illinois, will screen and recruit pregnant or postpartum women on HIV meds for prevention of mother-to-child transmission of HIV.

Hepatitis C Study Using Antiviral Treatment: Study of a thrombopoietin receptor agonist, for 12 weeks in subjects with chronic hepatitis C-related thrombocytopenia who are potential candidates for antiviral treatment with pegylated interferon and ribavirin.

Plasma Donation for Influenza Antibodies: Plasma donation for influenza vaccinated or infected subjects

Policosonal for Dyslipidemia in HIV: Policosonal for dyslipidemia in HIV

Study Of TYZEKA with Compensated Chronic Hepatitis B Virus Infection: Study of TYZEKA in subjects of Black/African American or Hispanic/Latino origin with compensated chronic hepatitis B virus infection

Three Non-NNRTI-Sparing Antiretroviral Regimens: The purpose of this study is to compare the effectiveness and tolerability of three combination FDA-approved HIV medication regimens using Truvada (emtricitabine/tenofovir disoproxil fumarate) as a base.

Zoster Vaccine in HIV-Infected Adults: The purpose of this study is to determine if Zostavax, an FDA-approved vaccine, is safe, effective and tolerable for HIV-infected adults.



Promotional Information

Clinical Trials Home
Infectious Disease Trials
Chronic HBV Infection Study
Dyslipidemia in HIV
HIV AIDS Clinical Trials Antiretroviral Naive
HIV Infection (Initial Therapy)
HIV positive women
HIV+ With Resistance to NRTIs and NNRTIs
HIV/AIDS Promoting Maternal and Infant Survival Everywhere
HIVAIDS Early Intervention
HIVAIDS Three Non-NNRTI-Sparing Antiretroviral Regimens
Hepatitis C Study Using Antiviral Treatment
Plasma Donation for Influenza Antibodies
Study Of TYZEKA with Compensated Chronic Hepatitis B Virus Infection
Zoster Vaccine in HIV Infected Adults

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois